# Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge

> **NCT01260753** · PHASE2 · COMPLETED · sponsor: **Palau Pharma S.L.U.** · enrollment: 24 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** UR-63325
- **DRUG:** Fluticasone propionate nasal spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01260753
- **Lead sponsor:** Palau Pharma S.L.U.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2011-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01260753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01260753, "Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01260753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*